How to buy OrganiGram stock - 10 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OrganiGram stock

Own OrganiGram stock in just a few minutes.

OrganiGram Holdings Inc is a drug manufacturers-specialty & generic business based in the US. OrganiGram shares (OGI) are listed on the NASDAQ and all prices are listed in US Dollars. OrganiGram employs 516 staff and has a trailing 12-month revenue of around USD$64.3 million.

How to buy shares in OrganiGram

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for OrganiGram. Find the stock by name or ticker symbol: OGI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OrganiGram reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OrganiGram, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of OrganiGram. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OrganiGram share price

Use our graph to track the performance of OGI stocks over time.

OrganiGram shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$1.01 - USD$6.45
50-day moving average USD$3.4424
200-day moving average USD$2.0476
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.2589

Buy OrganiGram shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OrganiGram stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OrganiGram financials

Revenue TTM USD$64.3 million
Gross profit TTM USD$-50,395,000
Return on assets TTM -16.97%
Return on equity TTM -52.4%
Profit margin -209.49%
Book value $1.09
Market capitalisation USD$938.6 million

TTM: trailing 12 months

Shorting OrganiGram shares

There are currently 14.2 million OrganiGram shares held short by investors – that's known as OrganiGram's "short interest". This figure is 26.1% up from 11.3 million last month.

There are a few different ways that this level of interest in shorting OrganiGram shares can be evaluated.

OrganiGram's "short interest ratio" (SIR)

OrganiGram's "short interest ratio" (SIR) is the quantity of OrganiGram shares currently shorted divided by the average quantity of OrganiGram shares traded daily (recently around 23.7 million). OrganiGram's SIR currently stands at 0.6. In other words for every 100,000 OrganiGram shares traded daily on the market, roughly 600 shares are currently held short.

However OrganiGram's short interest can also be evaluated against the total number of OrganiGram shares, or, against the total number of tradable OrganiGram shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OrganiGram's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 OrganiGram shares in existence, roughly 50 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable OrganiGram shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OrganiGram.

Find out more about how you can short OrganiGram stock.

OrganiGram share dividends

We're not expecting OrganiGram to pay a dividend over the next 12 months.

Have OrganiGram's shares ever split?

OrganiGram's shares were split on a 67:1 basis on 27 January 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 67 shares. This wouldn't directly have changed the overall worth of your OrganiGram shares – just the quantity. However, indirectly, the new 98.5% lower share price could have impacted the market appetite for OrganiGram shares which in turn could have impacted OrganiGram's share price.

OrganiGram share price volatility

Over the last 12 months, OrganiGram's shares have ranged in value from as little as $1.01 up to $6.45. A popular way to gauge a stock's volatility is its "beta".

OGI.US volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OrganiGram's is 1.4429. This would suggest that OrganiGram's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OrganiGram overview

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site